By Peter Nurse Investing.com - European stock markets slumped Monday, dragged lower by the losses in the banking sector on concerns of potential contagion from the collapse of U.S. lender...
By Peter Nurse Investing.com - European stock markets are expected to open in a cautious manner Monday, with investors digesting the moves by U.S. regulators over the weekend to support...
ZURICH (Reuters) – Novartis has launched a new share buyback programme to purchase up to 10% of the pharma company’s own shares over the next three years.
Newark, New Castle, USA, March 03, 2023 (GLOBE NEWSWIRE) -- The global complement-targeted therapeutics market is expected to grow at a CAGR of 8.9% from 2022 to 2030, owing to the rising...
Novartis AG (NYSE: NVS) has decided to terminate the Collaboration and License Agreement with Pliant Therapeutics, Inc.(NASDAQ: PLRX), announced in 2019. Novartis told Pliant that the move...
Newark, New Castle - 19702, USA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- According to the deep-dive market assessment study by Growth Plus Reports, the global menorrhalgia market was valued at...
By Brendan Pierson (Reuters) – Swiss drugmaker Novartis AG has agreed to pay $30 million to settle claims by health plans and consumers that it schemed to delay the U.S. launch of...
Newark, New Castle, USA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, "T-Cell Therapy Market by Type (CAR T-Cell Therapy, TCR Based), Modality...
ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year.
Radioligand therapy is a 'game -hanger' for cancer treatment, but it forces manufacturers to race against a ticking clock.
Newark, New Castle, USA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The global "Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Market Size" is expected to rise with an impressive CAGR...
Highlights from Fortune's dinner in Davos.
By Scott Kanowsky Investing.com -- European equities were mixed on Wednesday but widely held near the flatline, as investors awaited the highly anticipated release of the Federal Reserve's...
Newark, New Castle, USA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The global "Critical Care Antiarrhythmic Drugs Market Size" is expected to rise with an impressive CAGR and generate the highest...
Novartis AG (NYSE: NVS) has reported Q4 core EPS of $1.52 compared to $1.40 a year ago, beating the consensus of $1.44. Net sales were $12.69 billion, down 4% Y/Y or up 3% at constant...
Novartis posts lower sales, profit on generic hit but lifts dividend
The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment in Roche Holding.
BASEL (Reuters) – Swiss drugmaker Novartis on Wednesday predicted that core operating income would grow in a “mid single digit” percentage range in 2023, following stagnation last...
By Laura Sánchez Investing.com -- Danelfin has released its new December ranking of the stocks most likely to beat the market. Until now, the monthly rankings were based solely on the AI...
By Sarina Isaacs and Senad Karaahmetovic Investing.com - Here are the biggest management and board changes from the past week, as first reported on InvestingPro+. Keurig Dr Pepper...
By Scott Kanowsky Investing.com -- European stock markets opened broadly higher on Tuesday, continuing the previous session's positive tone as investors digest quarterly earnings from the...
By Peter Nurse Investing.com - European stock markets are expected to open marginally higher Tuesday, continuing the previous session’s positive tone as investors digest quarterly earnings...
By Scott Kanowsky Investing.com -- Novartis AG (SIX:NOVN) says it plans to petition the U.S. Supreme Court to uphold the validity of its patent for a dosing regimen of its blockbuster...
By Peter Nurse Investing.com - European stock markets are expected to open lower Wednesday, as investors braced for another hefty interest rate hike by the U.S. Federal Reserve, likely...
By Scott Kanowsky Investing.com -- Novartis AG (SIX:NOVN) has confirmed that the Swiss competition commission (COMCO) has visited the Basel headquarters of the drugmaker in connection...
By Peter Nurse Investing.com - European stock markets edged higher Thursday, stabilizing after losses earlier in the week, but sentiment remains fragile as investors fret about the impact of...
By Peter Nurse Investing.com - European stock markets are expected to open largely marginally lower Thursday, stabilizing after losses earlier in the week, but sentiment remains fragile as...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
